Insmed Incorporated (Nasdaq CM: INSMD), a biopharmaceutical company, today announced that it has received notification from The NASDAQ Stock Market that it has regained compliance with the minimum $1.00 per share bid price requirement.
To regain compliance with the bid price rule, Insmed was required to maintain a minimum closing bid price of $1.00 per share or more for a period of at least 10 consecutive business days. On March 16, 2011, the closing price of Insmed's common stock was $5.02 per share, the tenth consecutive business day the stock price had closed above $1.00 per share. The NASDAQ Capital Market has indicated that this matter in now closed.
Insmed will continue to trade on The NASDAQ Capital Market.
March 21, 2011
citybizlist
Tuesday, March 22, 2011
Insmed Regains NASDAQ Compliance
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment